DelMar Pharmaceuticals CEO Saiid Zarrabian receives $939K in 2018
DelMar Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: May 14, 2019
DelMar Pharmaceuticals reported fiscal year 2018 executive compensation information on May 14, 2019.
In 2018, four executives at DelMar Pharmaceuticals received on average a compensation package of $502K, a 4% increase compared to previous year.
Average pay of disclosed executives at DelMar Pharmaceuticals
Saiid Zarrabian, Chief Executive Officer, received $939K in total. 66% of Zarrabian's compensation, or $616K, was in option awards. Zarrabian also received $86K in bonus and $237K in salary.
Jeffrey Bacha, Chief Executive Officer, received a compensation package of $660K, which increased by 8% compared to previous year. 81% of the compensation package, or $538K, was in salary.
Scott Praill, Chief Financial Officer, earned $210K in 2018, a 45% decrease compared to previous year.
Dennis Brown, Chief Scientific Officer, received $200K in 2018, which decreases by 57% compared to 2017.
DelMar Pharmaceuticals' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on May 14, 2019.